Work

Neoadjuvant tislelizumab plus chemotherapy in MSS/pMMR high-risk locally advanced colon cancer: Updated analysis results from a phase 2 trial.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.3638

Authors: Minglin Lin, Zhiyuan Xia, Ming Qiu, Haining Chen, Cun Liao, Wei Huang, Hui Li, Jiahao Huang, Rui Song, Yuen Xie, Xiaolong Zhang, Junlin Liang, Jialiang Gan, Yun Guo, Sen Zhang

Institution: First Affiliated Hospital of GuangXi Medical University

Language: English

Topic: Colorectal Cancer Surgical Treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162562955

Cites:

Cited by:

Related to: